» Authors » Dorcas Fulton

Dorcas Fulton

Explore the profile of Dorcas Fulton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 412
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramaswamy V, Hielscher T, Mack S, Lassaletta A, Lin T, Pajtler K, et al.
J Clin Oncol . 2016 Jun; 34(21):2468-77. PMID: 27269943
Purpose: Posterior fossa ependymoma comprises two distinct molecular variants termed EPN_PFA and EPN_PFB that have a distinct biology and natural history. The therapeutic value of cytoreductive surgery and radiation therapy...
2.
Boychak A, Bauman G, Fisher B, Abdulkarim B, Amanie J, Fulton D, et al.
Am J Clin Oncol . 2014 Jan; 39(2):160-6. PMID: 24457533
Objectives: To evaluate longitudinal quality of life and late neurotoxicity (>12 mo) of tomotherapy in patients with primary benign and low-grade brain tumors. Methods: Between January 2006 and October 2009,...
3.
Jastaniyah N, Murtha A, Pervez N, Le D, Roa W, Patel S, et al.
Radiat Oncol . 2013 Feb; 8:38. PMID: 23425509
Purpose: To determine the safety and efficacy of hypofractionated intensity modulated radiation therapy (Hypo-IMRT) using helical tomotherapy (HT) with concurrent low dose temozolomide (TMZ) followed by adjuvant TMZ in patients...
4.
Quon H, Brunet B, Alexander A, Murtha A, Abdulkarim B, Fulton D, et al.
Anticancer Res . 2011 Oct; 31(10):3559-65. PMID: 21965778
Aim: To determine any correlation between magnetic resonance spectroscopy (MRS) pattern of high-grade glioma before, during, and after radiotherapy (RT) with overall survival (OS) and progression-free survival (PFS). Patients And...
5.
Perry J, Belanger K, Mason W, Fulton D, Kavan P, Easaw J, et al.
J Clin Oncol . 2010 Mar; 28(12):2051-7. PMID: 20308655
PURPOSE Concomitant temozolomide (TMZ)/radiotherapy followed by adjuvant TMZ has increased survival in patients with glioblastoma multiforme (GBM). However, few options are effective for patients who experience treatment failure. We conducted...
6.
Roa W, Chen H, Fulton D, Gulavita S, Shaw A, Thng J, et al.
Clin Invest Med . 2003 Nov; 26(5):231-42. PMID: 14596484
Introduction: The X-chromosome-linked inhibitor of apoptosis protein (XIAP) prevents apoptosis from activated transmembrane death receptors and confers tumour resistance to irradiation and chemotherapy. Despite the important oncologic implications, data concerning...
7.
Forsyth P, Weaver S, Fulton D, Brasher P, Sutherland G, Stewart D, et al.
Can J Neurol Sci . 2003 May; 30(2):106-12. PMID: 12774949
Objective: We conducted a clinical trial to determine if prophylactic anticonvulsants in brain tumour patients (without prior seizures) reduced seizure frequency. We stopped accrual at 100 patients on the basis...
8.
Jaeckle K, Batchelor T, ODay S, Phuphanich S, New P, Lesser G, et al.
J Neurooncol . 2002 Jul; 57(3):231-9. PMID: 12125986
Drugs currently available for intrathecal administration are cleared rapidly from the CSF. DepoCyt is a slow-release formulation of cytarabine that maintains cytotoxic concentrations of free cytarabine in the CSF for...